- Valbiotis announces the appointment of Charlotte JEZEQUEL as Director of Human Relations and Executive Committee member. Voir le communiqué de presse
- METabolic EXplorer publishes its Sustainability 2022 report (IN FRENCH). Voir le communiqué de presse
- Valbiotis announces the large success of the REVERSE-IT international multicentric Phase II/III clinical study on TOTUM•63: proven efficacy on the main risk factor of developing type 2 diabetes. Voir le communiqué de presse
- Limagrain starts its recruitment campaign! 600 seasonal crops are expected for its summer and autumn harvests (IN FRENCH). Voir le communiqué de presse
- Valbiotis announces its Combined Shareholders General Meeting will be held on May 2, 2023. Voir le communiqué de presse
- The pharmaceutical site of Riom La Varenne for 10 years within the SMO Biopôle Clermont-Limagne (IN FRENCH). Voir le communiqué de presse
- Valbiotis announces the last visit of the last patient in the Phase II/III REVERSE-IT study on TOTUM•63, in partnership with Nestlé Health Science. Voir le communiqué de presse
